Measles virus vaccine live subcutaneous - Lederle Laboratories/Serum Institute of India

Drug Profile

Measles virus vaccine live subcutaneous - Lederle Laboratories/Serum Institute of India

Alternative Names: Live, attenuated Measles virus (Edmonston-Zagreb strain) propagated on human diploid cells (HDC) - Serum Institute of India; M-VAC

Latest Information Update: 09 Apr 2014

Price : $50

At a glance

  • Originator Lederle Laboratories
  • Developer Serum Institute of India
  • Class Measles vaccines; Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Measles

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top